We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 5880Z
GlaxoSmithKline PLC
20 May 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ======================================================================== a) Name Mr P Thomson === ======================== ============================================== b) Position/status President, Global Affairs === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================== b) Nature of the Acquisition of Ordinary Shares following transaction the exercise of options granted on 29 October 2015 at the option price of GBP10.13 per Ordinary Share under the Company's ShareSave Plan. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) GBP10.13 533 ---------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2019-05-17 === ======================== ============================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== ==============================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLBLFLKEFZBBX
(END) Dow Jones Newswires
May 20, 2019 08:44 ET (12:44 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions